Literature DB >> 22959112

Circadian dimension and severity of depression.

Philippe Courtet1, Emilie Olié.   

Abstract

The cyclic nature of depressive illness, disturbance of diurnal mood variations, and disturbed sleep-wake and physiological rhythms all suggest that dysfunction of the circadian time-keeping system may underlie the pathophysiology of depression. Circadian misalignment of the phase-delayed type appears to be the most common shift in unipolar disorder patients and misalignment between the timing of sleep and the pacemaker is correlated with depressive symptom severity. Profiles of diurnal mood variation are associated with risks of depression severity and may predict response to treatments. As circadian disturbances are at the core of depression, normalizing circadian rhythm may be a fruitful avenue for new therapeutic targets in depression. The innovative antidepressant agomelatine possesses resynchronizing properties that may be related to its original profile and offers an opportunity to achieve our goals in treating depressed people.
Copyright © 2012 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22959112     DOI: 10.1016/j.euroneuro.2012.07.009

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  17 in total

1.  A rest-activity biomarker to predict response to SSRIs in major depressive disorder.

Authors:  W Vaughn McCall
Journal:  J Psychiatr Res       Date:  2015-03-06       Impact factor: 4.791

Review 2.  Biomarkers for Deep Brain Stimulation in Animal Models of Depression.

Authors:  Jason Yuen; Aaron E Rusheen; Joshua Blair Price; Abhijeet S Barath; Hojin Shin; Abbas Z Kouzani; Michael Berk; Charles D Blaha; Kendall H Lee; Yoonbae Oh
Journal:  Neuromodulation       Date:  2022-02

3.  Dendritic cell nuclear protein-1 regulates melatonin biosynthesis by binding to BMAL1 and inhibiting the transcription of N-acetyltransferase in C6 cells.

Authors:  Dong Chen; Yi-Pei Li; Yan-Xia Yu; Tian Zhou; Chao Liu; Er-Kang Fei; Feng Gao; Chen-Chen Mu; Hai-Gang Ren; Guang-Hui Wang
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

4.  What's in a delayed bathyphase?

Authors:  Stephen F Smagula
Journal:  J Psychiatr Res       Date:  2015-06-05       Impact factor: 4.791

Review 5.  Diabetes and depression.

Authors:  Richard I G Holt; Mary de Groot; Sherita Hill Golden
Journal:  Curr Diab Rep       Date:  2014-06       Impact factor: 4.810

6.  The effects of COVID-19 stay-at-home order on sleep, health, and working patterns: a survey study of US health care workers.

Authors:  Deirdre A Conroy; Nicole L Hadler; Echelle Cho; Aliya Moreira; Chamisa MacKenzie; Leslie M Swanson; Helen J Burgess; J Todd Arnedt; Cathy A Goldstein
Journal:  J Clin Sleep Med       Date:  2021-02-01       Impact factor: 4.062

7.  NIDDK international conference report on diabetes and depression: current understanding and future directions.

Authors:  Richard I G Holt; Mary de Groot; Irwin Lucki; Christine M Hunter; Norman Sartorius; Sherita H Golden
Journal:  Diabetes Care       Date:  2014-08       Impact factor: 19.112

Review 8.  Biomarkers for Deep Brain Stimulation in Animal Models of Depression.

Authors:  Jason Yuen; Aaron E Rusheen; Joshua Blair Price; Abhijeet S Barath; Hojin Shin; Abbas Z Kouzani; Michael Berk; Charles D Blaha; Kendall H Lee; Yoonbae Oh
Journal:  Neuromodulation       Date:  2021-06-09

Review 9.  Efficacy and tolerability of agomelatine in the treatment of depression.

Authors:  Blanka Kores Plesničar
Journal:  Patient Prefer Adherence       Date:  2014-05-02       Impact factor: 2.711

Review 10.  The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.

Authors:  Domenico De Berardis; Stefano Marini; Michele Fornaro; Venkataramanujam Srinivasan; Felice Iasevoli; Carmine Tomasetti; Alessandro Valchera; Giampaolo Perna; Maria-Antonia Quera-Salva; Giovanni Martinotti; Massimo di Giannantonio
Journal:  Int J Mol Sci       Date:  2013-06-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.